Premune

The company is based on the discoveries made from 15 years of clinical birth cohort studies showing that early stimulation by bacterial superantigens induce the natural tolerance mechanisms of the immune system. This stimulation significantly reducing the risk of developing allergies and implies the next generation of allergy prevention.